EP1853718
And-CD19 mótefni og notkun í krabbameinslækningum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.2.2006EP published:
5.8.2015EP application number:
06735370.6
EP translation filed:
29.10.2015Grant published:
15.11.2015EPO information:
European Patent Register
Max expiry date:
14.2.2026Expiry date:
14.2.2026
Title:
ANTI-CD19 ANTIBODIES AND USES IN ONCOLOGY
Timeline
Today
15.2.2006EP application
5.8.2015EP Publication
29.10.2015Translation submitted
15.11.2015Registration published
14.2.2026Expires
Owner
Name:
Duke UniversityAddress:
230 North Building, Research Drive, Box 90083, 27708-0083, Durham, NC, US
Inventor
Name:
YAZAWA, NorihitoAddress:
Tokyo, JP
Name:
GRON, HanneAddress:
Durham, NC, US
Name:
HAMAGUCHI, YasuhitoAddress:
Kanazawa,Ishikawa, JP
Name:
TEDDER, Thomas F.Address:
Durham, NC, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
653587 PDate:
15.2.2005Country:
US
Number:
702063 PDate:
22.7.2005Country:
US
Classification
Categories:
A61K 39/395, C12P 21/08, C07K 16/00, C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 20.1.2016
Expires: 14.2.2017
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 9.1.2017
Expires: 14.2.2018
Payer: Árnason Faktor
Number: 13
Paid: 8.1.2018
Expires: 14.2.2019
Payer: Árnason Faktor
Number: 14
Paid: 9.8.2019
Expires: 14.2.2020
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 20.1.2020
Expires: 14.2.2021
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 19.1.2021
Expires: 14.2.2022
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 18.1.2022
Expires: 14.2.2023
Payer: Patice ehf.
Number: 18
Paid: 19.1.2023
Expires: 14.2.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 18.1.2024
Expires: 14.2.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 20.1.2025
Expires: 14.2.2026
Payer: Árnason Faktor ehf.